摘要 |
Described herein is the LPAl antagonist {4'-[3-methyl-4-((R)-l-phenyl-ethoxycarbonylamino)-isoxazol-5-yl]-biphenyl-4-yl}-acetic acid (Compound 1), including pharmaceutically acceptable salts thereof. Also described are methods of preparing the LPAl antagonist, or pharmaceutically acceptable salts thereof, as well as pharmaceutical compositions suitable for administration to a mammal that include the LPAl antagonist, or pharmaceutically acceptable salt thereof, and methods of using such pharmaceutical compositions for treating LPA-dependent or LPA-mediated diseases or conditions. |
申请人 |
AMIRA PHARMACEUTICALS, INC.;BRITTAIN, JASON, EDWARD;SEIDERS, THOMAS, JON;KING, CHRISTOPHER, DAVID |
发明人 |
BRITTAIN, JASON, EDWARD;SEIDERS, THOMAS, JON;KING, CHRISTOPHER, DAVID |